
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+18
Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customers...
Stem cells,ipsc,cardiomyocytes,neurons,drug discovery,drug development,cardiovascular safety,cardiovascular efficacy,neural safety,neural efficacy,cro,fibroblast,astrocytes,electrophysiology,safety pharmacology,toxicology,assay development,contraction assays,custom cell lines,assay solutions,disease modeling,hts,and cmo
Ncardia operates in the Biotechnology research industry.
Ncardia's revenue is 11m - 100m
Ncardia has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.